Spectral Diagnostics (OTCMKTS:EDTXF) Trading Down 0.3% – Here’s Why

Spectral Diagnostics Inc. (OTCMKTS:EDTXF)’s share price dropped 0.3% during trading on Wednesday . The company traded as low as $0.9830 and last traded at $0.9830. Approximately 21,191 shares were traded during mid-day trading, an increase of 187% from the average session volume of 7,392 shares. The stock had previously closed at $0.9860.

Spectral Diagnostics Price Performance

The stock has a market cap of $288.56 million, a PE ratio of -9.83 and a beta of 0.11. The company has a 50 day moving average price of $0.98 and a two-hundred day moving average price of $0.99.

Spectral Diagnostics (OTCMKTS:EDTXF) last released its quarterly earnings data on Friday, May 8th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $0.64 million for the quarter, compared to analysts’ expectations of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.